SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Buffalo Early Stage Growth Fund (BUFOX) 当前追踪市盈率 (P/E) 为 4.7. 追踪盈利收益率为 21.10%. PEG 0.08 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (100/100, 通过) — 市盈率低于市场平均水平 (4.7); PEG ≤ 1.0 — Peter Lynch 低估标准 (0.08); 盈利收益率超过债券收益率 (21.10%).
- PEG 比率 0.08 — 低于1.0表明股票相对于其盈利增长率被低估（Peter Lynch 标准）。
- 追踪盈利收益率 21.10% — 超过典型债券收益率（约4.3%），使股票相对固定收益更具吸引力。
SharesGrow 综合评分： 72/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✓
健康
83/100
Debt-to-Equity & liquidity
→ Health
估值概览 — BUFOX
估值倍数
P/E (TTM)4.7
前瞻 P/EN/A
PEG 比率0.08
前瞻 PEGN/A
P/B 比率0.00
P/S 比率45.88
EV/EBITDA0.0
每股数据
EPS (TTM)$3.48
每股账面价值$0.00
每股营收$0.36
每股自由现金流$0.00
收益率与内在价值
盈利收益率21.10%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2013 |
$5.14 |
$7.11M |
$99.56M |
1399.5% |
| 2014 |
$7.31 |
$13.15M |
$141.44M |
1075.6% |
| 2015 |
$-10.41 |
$18.87M |
$-201.57M |
-1068.4% |
| 2016 |
$2.18 |
$8.57M |
$42.25M |
493% |
| 2017 |
$-0.25 |
$12.58M |
$-4.96M |
-39.5% |
| 2018 |
$0.86 |
$10.87M |
$17.25M |
158.7% |
| 2019 |
$0.93 |
$13.7M |
$18.55M |
135.4% |
| 2020 |
$-5.60 |
$3.41M |
$-110.77M |
-3245.6% |
| 2021 |
$2.22 |
$5.78M |
$43.13M |
746.3% |
| 2022 |
$3.48 |
$7M |
$67.79M |
967.9% |
